We previously reported the fusion of the TEL gene to the Syk gene in myelodysplastic syndrome with t(9;12)(q22;p12). TELSyk fusion transformed interleukin-3 (IL-3)-dependent murine hematopoietic cell line BaF3 to growth factor independence. Here, we investigate the intracellular signal transduction of the stable transfectants. TEL-Syk fusion protein was associated with the p85 subunit of phosphatidyl inositol 3 kinase (PI3-K) followed by the activation of Akt in the absence of IL-3. Vav, phospholipase C-c2 and mitogen-activated protein kinase (MAPK) were also constitutively activated. TEL-Syk also activated the signal transducer and activator of transcription 5 (STAT5) in the absence of Janus kinase 2 activation. None of these kinases were phosphorylated in the BaF3 cells transfected with TELDPNT-Syk in which the oligomerization domain of TEL was deleted. Inhibitor analysis showed that the MAPK pathway was important in TEL-Syk-mediated cell proliferation. The immunofluorescence technique revealed that the TEL-Syk fusion protein was located in the cytoplasm. These data suggest that TEL-Syk fusion protein in the cytoplasm leads to the constitutive activation of PI3-K/Akt, MAPK and STAT5 signal pathways, which are closely involved in IL-3-independent cell proliferation of BaF3 cells.
Introduction
Protein tyrosine kinase plays an important role in cell growth and oncogenesis. Receptor tyrosine kinases and tyrosine kinaseassociated receptors are activated by ligand binding with their extracellular domain and transduce an extracellular signal to the inside. Some tyrosine kinase-associated receptors have no inherent kinase activity but can regulate the hematopoietic system by activating nonreceptor protein tyrosine kinases. The deregulation of their signaling plays a significant role in the malignant transformation of hematological disorders. 1, 2 Syk is a nonreceptor tyrosine kinase that is widely expressed in a variety of hematopoietic cells. In the B-lineage lymphoid cell, Syk is a key regulator of signal transduction and differentiation. It has two amino-terminal Src-homology 2 domains and a carboxy-terminal kinase domain, binds to the immunoreceptor tyrosine-based activation motif (ITAM) and initiates signaling through the Ras, phosphatidyl inositol 3 kinase (PI3-K) and phospholipase C-g (PLC-g) signal pathways. [3] [4] [5] [6] Syk-deficient mice show a maturational block at the pro-B to pre-B cell transition. 7, 8 Aberrant splicing and protein deficiency of Syk was found in childhood pro-B cell acute lymphoblastic leukemia (ALL). 9 The TEL-Syk fusion observed in myeloid cells resulted in myeloid dysplasia and transformation in the presented case. 10 Syk is also reported to be an important suppressor of breast cancer cell growth and metastasis. 11 Chromosomal translocation is one of the mechanisms that leads to the generation of activated tyrosine kinase fusions. A significant number of chromosomal rearrangements fuse the ETS transcriptional repressor TEL with receptor or nonreceptor tyrosine kinase in many hematological malignancies. 12, 13 The TEL pointed self-association motif (PNT)-mediated oligomerization leads to the constitutive activation of tyrosine kinase fusion that is essential for cell transformation. The reported fusion genes of TEL with tyrosine kinases in hematological disorders are TEL-PDGFbR in chronic myelomonocytic leukemia, 14 TEL-ABL in ALL, 15 TEL-Janus kinase 2 (JAK2) in ALL and chronic myeloid leukemia (CML), 16, 17 TEL-TRKC in acute myeloid leukemia (AML), 18 TEL-ARG in AML 19 and TEL-Syk in myelodysplastic syndrome (MDS). 20 The JAK-STAT pathway is widely used by members of the cytokine receptor superfamily. 21, 22 Dysregulation of the JAK-STAT pathway has been observed in a large number of hematopoietic malignancies. 23 TEL-JAK2 fusions in lymphoid and myeloid leukemia patients led to the constitutive activation of the tyrosine kinase and conferred cytokine-independent proliferation to the interleukin-3 (IL-3)-dependent BaF3 hematopoietic cell line. 16, 17 The activation of STAT5 plays a critical role in myelo-and lymphoproliferative TEL-JAK2 diseases; 24 however, serine/threonine phosphorylation is also important in intracellular signal transduction.
25 PI3-K/Akt signal pathway is also constitutively activated in the BaF3 cell transformed by TEL-JAK2. 26 Mitogen-activated protein kinase (MAPK) is constitutively activated in a majority of acute leukemia. 27 Aberrant expression of Raf oncoproteins can abrogate cytokine dependency of the hematopoietic cell lines TF-1 and FDC-P1. 28, 29 We previously reported the fusion of the TEL gene to Syk gene in a patient with MDS with t(9;12)(q22;p12). TEL-Syk fusion transformed IL-3-dependent murine hematopoietic cell line BaF3 to growth factor independence. TEL-Syk was constitutively tyrosine autophosphorylated. 10, 20 We here show intracellular signal components specifically activated in the TEL-Syk-transformed BaF3 cell.
Materials and methods

DNA constructs and expression plasmids
Full-length TEL-Syk and TELDPNT-Syk (deletion of nt 222-461in the TEL gene) cDNA were constructed by PCR as described previously. 20 PCR products were confirmed by sequencing to be devoid of mutations. We used retroviral expression vector pBabeNeo and Flag epitope-tagged expression vector pFlag (Invitrogen, San Diego, CA, USA). Retroviral expression vector pBabeNeo and pFlag have been described, respectively. 30, 31 We cloned the TEL-Syk and TELDPNT-Syk constructs into pBabeNeo (pB-TS and pB-TDPS) and cloned the TEL-Syk into pFlag (pF-TS) (Figure 1 ).
Cell transfection assays
The pCMV-G-containing vesicular stomatitis virus envelope glycoprotein was cotransfected with pB-TS and pB-TDPS or vector alone as a control into 293GP cells, a retrovirus packaging cell line expressing MMLV gag and pol genes. 32, 33 The IL-3-dependent murine leukemia BaF3 cells were infected with these supernatants in the presence of 5 mg/ml polybrene. G418-resistant BaF3 expressing the indicated proteins and control cells were grown in RPMI 1640 supplemented with 10% fetal calf serum (FCS) and 5 ng/ml recombinant murine IL-3.
COS-7 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% FCS. pF-TS was transfected into subconfluent COS-7 cells by Lipofectamin (Invitrogen).
Antibody
The antibodies used are as follows: anti-Syk 4D-10 monoclonal antibody (mAb) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-PI3-K p85 antisera (Upstate Biotechnology, Lake Placid, NY, USA), rabbit anti-phospho-Akt antisera (Cell Signaling Technology, Beverly, MA, USA), rabbit anti-Akt antisera (Cell Signaling Technology), rabbit anti-Vav antisera (Santa Cruz Biotechnology), rabbit anti-PLC-g1 antisera (Santa Cruz Biotechnology), rabbit anti-PLC-g2 antisera (Santa Cruz Biotechnology), rabbit anti-phospho-p44/42 MAPK antisera 
Immunoprecipitation
The BaF3 cells were grown to a density of approximately 1 Â 10 6 /ml. The cells were washed in phosphate-buffered saline (PBS) at 41C and lysed in a lysis buffer: 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10% glycerol, 0.5% NP-40, 1 mM Na 3 VO 4 , 50 mM NaF and protease inhibitor cocktail (Roche, Mannheim, Germany). The cell lysates were centrifuged and the supernatants were incubated with the indicated antibodies for 1 h followed by protein G-agarose (Invitrogen) for 2 h at 41C. The immunoprecipitates were washed four times in the lysis buffer.
Immunoblotting
Whole-cell lysates or immunoprecipitates were boiled with the electrophoresis SDS sample buffer for 3 min. The samples were separated by SDS-PAGE (polyacrylamide gel electrophoresis) and transferred onto polyvinylidine difluoride membranes (BioRad Laboratories, Hercules, CA, USA). The membrane blots were blocked with 5% skimmed milk in Tris-buffered saline (TBS) containing 0.05% Tween 20 (TBS-T), or 1% blocking reagent (pH 7.5) (Roche) for 1 h at 371C followed by incubation with primary antibodies in TBS-T for 2 h at room temperature or overnight at 41C. After being washed, the membranes were incubated with HRP-linked whole anti-mouse or anti-rabbit IgG antibody in TBS-T for 2 h at room temperature. After washing, an enhanced chemiluminescence assay was performed and positive bands were identified on the X-ray films.
Cell proliferation assay
Tetracolor One cell proliferation assay (Seikagaku Co., Tokyo, Japan) was performed as described. 34 The cells (1 Â 10 4 /well) were added to 96-well plates in 100 ml RPMI containing 10% FCS in the presence or absence of IL-3 with varying concentrations of LY294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benopyran-4-one] (Promega, Madison, WI, USA), the inhibitor of PI3-K or MEK inhibitor U0126 (Promega). The plates were incubated at 371C for 72 h before the addition of a mixture of tetrazolium [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt] and electron carrier (1-methoxy-5-methylphenazium methylsulfate) (final volume 110 ml/well). The cells were incubated for an additional hour at 371C, and the absorption of 450 nm was measured using an ELISA plate reader.
Immunofluorescence microscopy COS-7 cells were transfected with pF-TS using Lipofectamin (Invitrogen). The cells were grown on chamber slides. The transfected COS-7 cells were subjected to indirect immunofluorescence antibody staining 48 h after transfection. The cells were fixed with ice-cold methanol:acetone (1:1) and blocked in Figure 1 Schematic representation of constructed TEL-Syk and deletion mutant TELDPNT-Syk (deletion of nt 222-461). For high expression in BaF3 cells, TEL-Syk and TELDPNT-Syk were cloned into the pBabeNeo construct, a retroviral vector based on an MMLVexpressing neomycin-resistant gene. For immunofluorescence microscopy, TEL-Syk cDNA cloned into pFlag (the Flag epitope tagged) was used. LTR, long-terminal repeat; SV40, SV40 promoter; SV40pA, SV40 polyadenylation signal; CMV, CMV promoter.
Signaling by TEL-Syk T Kanie et al 1% BSA in PBS, and then anti-Flag mAb was added for 45 min. After washing the cells, goat anti-mouse IgG (FITC) was added for 30 min. The cells were then washed and incubated with 0.5 mg/ml propidium iodide (Sigma Aldrich, St Louis, MO, USA), which was used for fluorescent staining of the nucleic acid, for 5 min, washed again and coverslips were then mounted on chamber slides. The cells were visualized with a fluorescence microscope and photographed.
Results
TEL-Syk fusion protein activated the PI3-K/Akt signal pathway
We used the stable transfectants to unveil the intracellular signal transduction of TEL-Syk. Akt is a protein serine/threonine kinase and the major effector of the PI3-K pathway, which is activated in downstream signaling of Syk. 6, 35, 36 First, BaF3 cell lysates were immunoblotted with phospho-Akt antibody to assess the activation of the PI-3K/Akt signal pathway. Only in the TEL-Syktransformed BaF3 cell was Akt activated in the absence of IL-3 ( Figure 2a) . Next, the BaF3 cell lysates were immunoprecipitated with antibody against p85 PI3-K and immunoblotted with the human-specific anti-Syk mAb to assess the interaction between TEL-Syk and PI3-K. Interestingly, TEL-Syk fusion products were co-immunoprecipitated with the p85 subunit of PI3-K and this association was not observed in the BaF3 cell with TELDPNT-Syk in which the oligomerization domain was deleted (Figure 2b ).
Vav, PLC-g2 and MAPK signal pathways were constitutively activated in TEL-Syk-transformed BaF3 cells
Vav, the proto-oncogene product, is known to bind to nonreceptor protein tyrosine kinase. Nuclear phosphorylated Vav is associated to the p85 subunit of PI3-K and to PLC-g1 in HL-60 cells differentiated by all-trans retinoic acid. 37 BaF3 cell lysates were immunoprecipitated with antibody against Vav, PLC-g1 and PLC-g2, and immunoblotted with the mAb against phosphotyrosine. Vav and PLC-g2 were tyrosine phosphorylated in TEL-Syk-transformed BaF3 cells in the absence of IL-3; however, PLC-g1 was not activated (Figure 3a) .
MAPK, also known as extracellular signal-regulated kinase (ERK), is serine/threonine kinase that appears to be one of the key regulators of cell proliferation and differentiation. 25, 38, 39 BaF3 cell lysates were immunoblotted with the antibody against Signaling by TEL-Syk T Kanie et al phospho-ERK1/2 (p42/44 MAPK) and phospho-MEK1/2 (ERK kinase). Both ERK1/2 and MEK1/2 were constitutively activated in TEL-Syk-transformed BaF3 cells (Figure 3b ).
Constitutive tyrosine phosphorylation of STAT5 in the absence of JAK2 activation
STAT plays an important role in growth factor-mediated intracellular signal transduction. 40, 41 Dysregulation of the JAK-STAT pathway has been observed in many hematopoietic malignancies. 23 STATs were constitutively activated in some acute leukemia blasts. [42] [43] [44] [45] To assess the potential role of STATs phosphorylation in signaling by the TEL-Syk, BaF3 cell lysates were immunoprecipitated with antibody against STAT1, STAT3 and STAT5, and immunoblotted with the mAb against phosphotyrosine. STAT5 was tyrosine phosphorylated in TEL-Syktransformed BaF3 cells in the absence of IL-3. STAT1 and STAT3 activation were not detected because of the low expression in the BaF3 cells in the presence and absence of IL-3 (Figure 4a ). JAK2 phosphorylation was not detected in the absence of IL-3 and was inhibited in the presence of IL-3 in TEL-Syk-transformed BaF3 cells (Figure 4b ). The fact that the TEL oligomerization domain played a critical role in the activation of the kinases examined also strengthens our proposal that these signals are closely involved in tumor progression in TEL-Syk-induced leukemia.
MAPK signal pathway was required for TEL-Sykmediated cell proliferation
To determine which signal pathway is important in factorindependent cell growth, we performed cell proliferation assays with several concentrations of the PI3-K inhibitor, LY294002 and MEK inhibitor U0126.
A reduction in the number of BaF3 cells and TEL-Syktransformed BaF3 cells was observed with increasing LY294002 concentrations, even in the presence of IL-3. LY294002 suppressed both TEL-Syk-mediated and IL-3-induced BaF3 cell proliferation (Figure 5a ). To determine whether the activation of Akt is dependent on PI3-K, BaF3 cells were pretreated with LY294002 and immunoblotted with the antibody against phospho-Akt. The activation of Akt by TEL-Syk and IL-3 was blocked by LY294002, although phosphorylation of ERK1/2 and STAT5 was not blocked by LY294002 (Figure 5b ). These data suggest that PI3-K/Akt activation is important for both TEL-Sykmediated and IL-3-induced cell proliferation. Signaling by TEL-Syk T Kanie et al TEL-Syk-mediated BaF3 cell growth was selectively inhibited by MEK inhibitor U0126. TEL-Syk-mediated cell proliferation was suppressed more strongly than IL-3-mediated cell proliferation with 10-20 mM of U0126 (Figure 6a ). To determine whether growth inhibition is dependent on the activation of MAPK, BaF3 cells were pretreated with U0126 and immunoblotted with the antibody against phospho-ERK1/2. The activation of ERK1/2 by TEL-Syk was inhibited by U0126, although phosphorylation of Akt and STAT5 were not inhibited by U0126 (Figure 6b ). These data suggest that MAPK signal pathway is required for cytokineindependent cell proliferation.
TEL-Syk fusion protein was located in cytoplasm
TEL is a nuclear phosphoprotein that is widely expressed in normal tissues. 46, 47 Syk is distributed in cytosol and initiates signal transduction cascades in lymphoid cells. 4, 48 To determine the localization of TEL-Syk fusion protein, COS-7 cells transfected with pF-TS were stained with anti-Flag mAb and visualized with goat anti-mouse IgG (FITC). The immunofluorescence technique revealed the TEL-Syk fusion protein to be located in the cytoplasm (Figure 7a and b) . TEL-Syk fusion products, not in the nucleus but in the cytoplasm, led to the constitutive activation of PI3-kinase, MAPK and STAT5 signal pathways, which are important in the IL-3-independent cell proliferation of BaF3 cells.
Discussion
We investigated the intracellular signal transduction in TEL-Syktransformed BaF3 cells. Syk binds to ITAM and initiates signaling through the Ras, PI3-K and PLC-g signal pathways. 5, 6 We showed the association between the p85 subunit of PI3-K and TEL-Syk fusion protein followed by the constitutive activation of Akt. Akt is the serine/threonine kinase and an important component of cell survival signaling. Akt phosphorylates the BCL family member BAD and suppresses apoptosis. 49 Subsequently, apoptosis is inhibited by phosphorylation and inactivation of caspase-9.
50 TEL-Syk may play a critical role in antiapoptosis and cell survival of IL-3-depleted BaF3 through the suppression of the caspase pathway. Beitz et al 6 demonstrated that Syk plays a major role in linking the B-cell receptor to PI3-K activation; however, the Syk-dependent pathways for The MAPK signal pathway is required for TEL-Sykmediated cell proliferation. Signaling by TEL-Syk T Kanie et al PI3-K activation is not shown. Our data suggest that Syk and the p85 subunit of PI3-K may form a protein complex. Deregulation of the JAK-STAT pathway is observed in many hematopoietic malignancies. 23 STAT5 is phosphorylated and activated in a variety of leukemia cells containing tyrosine kinase oncogenes, including BCR-ABL, TEL-JAK2, TEL-PDGFbR and FLT3 with internal tandem duplication. 24, [51] [52] [53] However, the constitutive JAK activation is not necessarily required for transformation. 54 A constitutively active mutant of STAT5 is sufficient to induce factor independence of BaF3 cells. 55 We have previously reported the constitutive kinase activation of Syk and cytokine-independent proliferation in TEL-Syk-transformed BaF3 cells. 20 We here show the constitutive tyrosine phosphorylation of STAT5 in the absence of JAK2 activation and the suppression of IL-3-induced JAK2 phosphorylation in TELSyk-transformed BaF3 cells. The expression of JAB (also called SOCS-1) was unable to inhibit the growth of TEL-Syktransformed BaF3 cells and tyrosine phosphorylation of STAT5 (data not shown), although JAB can inhibit JAK signaling. 56, 57 The constitutive tyrosine kinase activation of TEL-Syk led to the activation of STAT5, not through the JAK-family members, while the exact transduction mechanism from TEL-Syk to STAT5 is not known. Klejman et al 58 recently reported hematopoietic cell kinase-coupled BCR-ABL to STAT5 activation. In vitro phosphorylation assay and in vitro interaction assay between STAT5 and TEL-Syk may reveal whether the interaction is direct. We do not know the reasons behind the downregulation of IL-3-induced JAK2 phosphorylation in TEL-Syk-transformed BaF3 cells, but hope to examine the functional activity of IL-3 receptor in TEL-Syk-transformed BaF3 cells in the future.
MAPK, also known as ERK, is serine/threonine kinase that appears to be one of a key regulator of cell proliferation and differentiation, and is constitutively activated in a majority of acute leukemia. 25, 27, 38 The upstream components of the MAPK pathway contain the Ras signaling cascade. ERK1/2 and MEK1/ 2, which were constitutively activated in the TEL-Syk-transformed BaF3 cells, might be activated through the Ras/Raf/MEK/ ERK cascade downstream of TEL-Syk signaling. MEK inhibitor U0126 selectively inhibited the TEL-Syk-mediated BaF3 cell growth and activation of MAPK. Constitutively activated form of MEK1 can transform NIH 3T3 and Chinese hamster fibroblast, 59, 60 and conditionally active form of MEK1 can also abrogate cytokine dependency of hematopoietic cell lines TF-1, FDC-P1 and FL5.12. 61, 62 These data suggest that the MAPK signal pathway is important in TEL-Syk-mediated BaF3 cell proliferation and might be one of the targets for chemotherapy in TEL-Syk disease.
Tyrosine kinase inhibitors are being explored in leukemia therapy. 2 The BCR-ABL tyrosine kinase inhibitor STI571 (Imatinib mesylate) has significant antileukemic activity in patients with CML. 63 Piceatannol, which is known as a Sykselective tyrosine kinase inhibitor, 64, 65 suppressed the survival and proliferation of TEL-Syk-transformed BaF3 cells and inhibited the phosphorylation of STAT5, but piceatannol also suppressed IL-3-induced BaF3 cell growth (data not shown). Piceatannol not only inhibits protein tyrosine kinase Syk but also interferes with other kinases and induces apoptosis in leukemic lymphoblasts. 66, 67 TEL-Syk fusion is a useful tool in the search for another Syk-specific inhibitor and for future investigation of Syk.
Recent reports suggest that Syk is a tumor suppressor. Goodman et al 9 reported that childhood pro-B-cell ALL is caused by Syk deficiency, and Coopman et al 11 showed that Syk suppresses breast cancer cell growth and metastasis. However, the TEL-Syk fusion gene was discovered in the presented case of myeloid dysplasia with unique clinical features, including skin involvement, dry cough and eosinophilia, and Syk was constitutively activated in hematopoietic cells. 10, 20 The presented evidence reveals another function of Syk constitutively activated by oligomerization through TEL, that of a stimulator of tumor progression.
